Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux-Reference-Cited by-同舟云学术

Apolipoprotein Mimetic Peptides for Stimulating Cholesterol Efflux

Published:2015 Issue: Volume: Page:29-42
ISSN:
Container-title:Apolipoprotein Mimetics in the Management of Human Disease
language:
Short-container-title:

Author:

Li Dan,Gordon Scott,Schwendeman Anna,Remaley Alan T.

Publisher

Springer International Publishing

Link

http://link.springer.com/content/pdf/10.1007/978-3-319-17350-4_3

Reference58 articles.

1. Amar MJ et al (2010) 5A apolipoprotein mimetic peptide promotes cholesterol efflux and reduces atherosclerosis in mice. J Pharmacol Exp Ther 334(2):634–641

2. Anantharamaiah GM et al (1985) Studies of synthetic peptide analogs of the amphipathic helix. Structure of complexes with dimyristoyl phosphatidylcholine. J Biol Chem 260(18):10248–10255

3. Anantharamaiah GM et al (1990) Use of synthetic peptide analogues to localize lecithin: cholesterol acyltransferase activating domain in apolipoprotein A-I. Arterioscler Thromb Vasc Biol 10(1):95–105

4. Anantharamaiah GM et al (1991) Role of Amphipathic helixes in hdl structure-function. hypercholesterolemia, hypocholesterolemia, hypertriglyceridemia. Invivo Kinetics 285:131–140

5. Bielicki JK et al (2010) A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice. J Lipid Res 51(6):1496–1503

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma;Angewandte Chemie International Edition;2023-11-06

2. Synthetic High‐Density Lipoprotein‐Based Nanomedicine to Silence SOCS1 in Tumor Microenvironment and Trigger Antitumor Immunity against Glioma;Angewandte Chemie;2023-11-06

3. Nanodiscoidal Nucleic Acids for Gene Regulation;ACS Chemical Biology;2023-11-01

4. Influence of lecithin cholesterol acyltransferase alteration during different pathophysiologic conditions: A 45 years bibliometrics analysis;Frontiers in Pharmacology;2022-12-14

5. Mechanistic Insights into the Activation of Lecithin–Cholesterol Acyltransferase in Therapeutic Nanodiscs Composed of Apolipoprotein A-I Mimetic Peptides and Phospholipids;Molecular Pharmaceutics;2022-09-16